Type 1 diabetes

Effect of Diactive-1 mHealth-Supported Progressive Resistance Training on Insulin Requirements, Glycemic Stability, and Muscular Strength in Children and Adolescents With Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial

Diabetes CarePublished Randomised controlled trial

Primary result · Daily insulin doseResult — go to the resultMD −0.17 units/kg 95% CI −0.26 to −0.07

Authors' conclusion

Diactive-1 appears to be a safe and feasible adjunct to standard care in children and adolescents with type 1 diabetes. Its resistance training component effectively reduced insulin requirements and improved muscular strength, without increasing the risk of adverse glycemic events.

Study context

Population
Children and adolescents aged 8–18 years with T1D (girls 48%; HbA1c 7.6% [60.4 mmol/mol])4 withdrew
Participants
62 children
Comparison
Diactive-1 mHealth-supported progressive resistance training vs usual care
  • Diactive-1n = 30
  • Usual caren = 32reference
Primary endpoint
Daily insulin dose
Follow-up
24 weeks
Methodological detailsparallel-group, 24-week
  • Parallel-group
  • 24-week

Primary result

As reported in the abstract

MD

−0.17 units/kg

95% CI −0.26 to −0.07

Diactive-1vs Usual care
MD −0.17 units/kg (95% CI −0.26 to −0.07)
Daily insulin dose reduction within Diactive-1
−0.10 (MD, units/kg; 95% CI −0.18 to −0.01)

Further findings

Handgrip strength increased
2.90 (MD, kg; 95% CI 1.57-4.22)
One-repetition maximum strength increased
1.34 (MD; 95% CI 0.21-2.46)
Muscular power increased
0.97 (MD; 95% CI 0.01-1.93)

Safety

Glycemic risk index and hypoglycemic events

No adverse effects observed on the glycemic risk index or the incidence of hypoglycemic events

Withdrawal

Participants withdrew from the study
4 (6.5%)

Original publication

Effect of Diactive-1 mHealth-Supported Progressive Resistance Training on Insulin Requirements, Glycemic Stability, and Muscular Strength in Children and Adolescents With Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial. Diabetes Care. Published 13 August 2025. doi:10.2337/dc25-0985

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.